Federal Forum Poster - Browse by Category

1-358 - Cost Analysis of Automatic Insulin Refills Upon Dose Adjustment

1-293 - Improving performance of a pharmacy inventory management system to reduce stock-outs on high-use medications

1-084 - A retrospective review of pharmacist interventions on patients identified by the VA Hypoglycemia Safety Initiative Tool at the VA Eastern Colorado Health Care System

1-243 - Advancing Patient Care Through a Novel Physical Assessment Course

1-109 - Ambulatory Care Sensitive Conditions and a Transition of Care Program

1-201 - Assessing A1C in multidisciplinary diabetes shared medical appointments

1-148 - Assessing Safety and Outcomes of GLP-1 Agonists With Basal and Bolus Insulin Regimen: Department of Veterans Affairs Quality Improvement Analysis

1-207 - Assessing the need and cost-effectiveness of a pharmacy-led hepatitis C clinic at a rural hospital

1-266 - Assessment of medication therapy management for prevention of cardiovascular disease in the Human Immunodeficiency Virus positive veteran population at the New York Harbor Healthcare System

1-376 - Assessment of renal-adjusted oral antihyperglycemic medications (metformin versus dipeptidyl peptidase-4 inhibitors) for glycemic control in patients with type 2 diabetes and moderate renal impairment

1-174 - Clinical effectiveness of an interprofessional model for the initiation and monitoring of empagliflozin for chronic kidney disease patients with diabetic nephropathy

1-188 - Clinical pharmacy specialist's role in antihypertensive management surrounding bariatric surgery in a Veteran population

1-041 - Comparison of pharmacist-led referral service vs provider-led management of uncontrolled hypertension

1-241 - Conversion from insulin vials to pens: impact on glycemic control and medication adherence in a Native American population

1-303 - Decentralization of the Pharmacist to an Endocrinology Service in a Diabetes Wellness Center

1-061 - Determining the effect of GLP-1 agonists on total daily insulin dose in veterans receiving concomitant insulin therapy

1-069 - Dipeptidyl peptidase-4 inhibitors and inflammatory bowel disease risk: a meta-analysis

1-402 - Dissemination and Implementation of an Interprofessional Training Program

1-214 - Educational training and schedule restructuring of primary care clinical pharmacy specialist clinics in a Veterans Affairs health care center

1-173 - Effect of continuous glucose monitor use on hemoglobin A1c in an adult veteran population with diabetes

1-065 - Effects of implementing a pharmacist-led injectable naltrexone clinic in patients with alcohol use disorder at an IHS facility

1-162 - Empagliflozin compared to liraglutide for weight loss among patients with type 2 diabetes

1-141 - Evaluating a Veterans Affairs (VA) home based primary care (HBPC) population for patients at high-risk of osteoporosis

1-230 - Evaluating the impact of education on clinical pharmacy specialists’ naloxone prescribing patterns in a VA hospital

1-110 - Evaluating the impact of patient aligned care team (PACT) pharmacists in the management of osteoporosis

1-238 - Evaluating the underutilization of statins in treatment-experienced patients with type 2 diabetes at the New Mexico Veterans Affairs Health Care System

1-265 - Evaluation and identification of veterans diagnosed with heart failure with reduced ejection fraction who are candidates for therapy optimization with sacubitril/valsartan

1-344 - Evaluation of a pharmacist-led chronic obstructive pulmonary disease (COPD) clinic

1-228 - Evaluation of a pharmacist-led monitoring process for vitamin B12 in metformin-treated veterans with type 2 diabetes

1-222 - Evaluation of academic detailing to increase naloxone distribution to high risk opioid patients within a Veterans Affairs Health Care System

1-304 - Evaluation of adherence to therapy and clinical measures in diabetic patients managed by a pharmacotherapy clinic

1-135 - Evaluation of clinical outcomes of veterans prescribed weight-loss medications in pharmacist-run clinic

1-368 - Evaluation of cost savings and glycemic control before and after the conversion from liraglutide 1.8 mg to liraglutide 1.2 mg at a veterans affairs hospital

1-334 - Evaluation of empagliflozin in Veterans for the treatment of type 2 diabetes mellitus at the Providence Veterans Affairs Medical Center (PVAMC)

1-095 - Evaluation of glycemic and weight changes after transitioning between glucagon-like peptide-1 receptor agonists to empagliflozin

1-338 - Evaluation of glycemic control following initiation of long-term oral corticosteroid therapy

1-287 - Evaluation of Patient-Aligned Care Team Clinical Pharmacy Specialists’ interventions for reducing hypoglycemia in a Veteran population

1-003 - Evaluation of patients referred to a clinical pharmacy specialist for diabetes management

1-308 - Evaluation of proton pump inhibitor therapy following discharge from internal medicine service in veterans: A Retrospective Chart Review

1-274 - Evaluation of solid organ transplant immunosuppression maintenance therapy monitoring at VA Hudson Valley Healthcare System (VA HVHCS)

1-198 - Expanding access to hepatitis C prevention and treatment services in a rural American Indian community

1-133 - Expansion of a pharmacist-managed asthma clinic in the Veterans Affairs Central Iowa Health Care System

1-043 - Factors affecting veteran utilization of multi-discipline services for the management of type II diabetes mellitus

1-357 - Going for the “GOLD”: Optimization of veterans’ COPD medications after hospitalization

1-332 - Impact of achieving sustained virologic response with interferon-free direct-acting antiviral therapies among Veterans with hepatitis C and substance use disorder

1-187 - Impact of multidisciplinary classes and pharmacy telephone follow-up appointments for targeted weight management in Veterans with prediabetes (TRIM)

1-147 - Impact of pharmacist-run chronic obstructive pulmonary disease (COPD) clinic on patient outcomes within the Veterans Affairs Illiana Healthcare System

1-171 - Impact on patient care access through conversion of primary care provider appointments to clinical pharmacist appointments

1-046 - Implementation and impact of a pharmacist-led transitions of care clinic in reducing readmissions for heart failure and chronic obstructive pulmonary disease

1-136 - Implementation of a pharmacist-driven intervention to improve outcome performance measures for statin therapy in diabetes patients

1-152 - Implementation of a pharmacist-managed transitions of care tool and program

1-001 - Implementation of a primary prevention, population-based virtual osteoporosis clinic dramatically increases the number of rural veterans receiving osteoporosis screening and treatment

1-342 - Implementation of an outpatient, pharmacist-led chronic obstructive pulmonary disease (COPD) transitions of care clinic in a rural Veterans Affairs health care system

1-305 - Implementing a pharmacy-initiated naloxone co-prescribing service in high risk patients

1-051 - Improving COPD transitions of care with an interdisciplinary primary care team

1-391 - Initiation and Implementation of Chart Review Clinic Locations for Patient Aligned Care Team Pharmacists

1-129 - Initiation of a PCSK-9 inhibitor for the management of resistant and/or complex hyperlipidemia through the use of a risk assessment tool

1-036 - Integration of pharmacist-led hepatitis C management into primary care within the Nuka System of Care

1-107 - Investigation of adverse outcomes of empagliflozin use in an elderly veteran population

1-219 - Management of hypoglycemia and hemoglobin A1c goal in Veterans Affairs (VA) pharmacist-run diabetes clinics

1-044 - Measuring the impact of a pharmacist run alcohol use disorder (AUD) walk-in clinic

1-324 - Medication transition clinic in a primary care setting

1-411 - Opioid Use Disorder Dashboard: Veterans within the Cheyenne VA who can benefit from pharmacist management

1-298 - Pilot of smartbooking tool to improve access at Wade Park Primary Care clinic

1-002 - Preparing outpatient pharmacies at an academic center for United States Pharmacopeia (USP) 800

1-284 - Project EVADE (Educating Veterans After DischargE): Evaluating the Effects of a Pharmacist-Run Transitions of Care Clinic on Hospital Readmissions

1-073 - Quantifying recommendations during pharmacy medication reconciliation calls for trainee-led primary care teams

1-185 - Renal Outcomes with Sodium-Glucose Co-Transporter-2 Inhibitor Use in Veterans with Type 2 Diabetes Mellitus

1-145 - Retrospective analysis of the effect of diabetes mellitus on sustained virologic response in hepatitis c patients treated with direct acting antiviral agents

1-389 - Retrospective evaluation of the effectiveness of insulin pumps in the veteran population

1-323 - Review of hyperglycemia management in hospitalized patients who are on glucocorticoid therapy, are overweight, or are obese

1-072 - Role of pharmacy residents in assessing COPD symptoms and education needs during medication reconciliation telephone visits at San Francisco Veterans Affairs Health Care System

1-296 - Standardization of pharmacy gout management service for reducing time to uric acid laboratory testing

1-212 - Success rate of statin rechallenge after the initiation of vitamin D supplementation in statin intolerant patients

1-345 - The discontinuation of buprenorphine post a long-term maintenance period in Veterans with opioid use disorder

1-285 - The Impact of Pharmacist Interventions in Dofetilide Monitoring

1-105 - The patient aligned care team (PACT) model: A comparative analysis of national standard patient centered measures following a regional PACT expansion

1-225 - Utilization of a pharmacy amiodarone monitoring note within a federal ambulatory care setting and its effect on amiodarone monitoring requirements

1-063 - Activated Partial Thromboplastin Time Versus Antifactor Xa Monitoring in Veterans with ACS Receiving Unfractionated Heparin Infusion

1-097 - Adverse events related to obesity and direct oral anticoagulants (DOACs)

1-292 - Amiodarone Monitoring Assessment: A Medication-Use Evaluation (MUE)

1-413 - Assessing the impact of a pharmacist-led pharmacotherapy clinic in Veteran patients with heart failure

1-312 - Clinical pharmacist impact on 30-day heart failure readmission rates

1-370 - Comparison of direct-acting oral anticoagulants in veterans prescribed triple therapy

1-291 - Comparison of inpatient warfarin monitoring by pharmacists versus hospitalists at a VA medical center

1-146 - Comparison of the safety of rivaroxaban and apixaban in the treatment of venous thromboembolism and nonvalvular atrial fibrillation

1-100 - Concomitant use of non-steroidal anti-inflammatory drugs and direct oral anticoagulants

1-052 - Direct oral anticoagulants conversion to improve time in therapeutic range and patient outcomes for patients on warfarin therapy at Phoenix Veterans Affairs Health Care System

1-166 - Effect of Beta Blocker Therapy on Major Cardiovascular Outcomes in Cocaine Users: A Single-Center Retrospective Cohort Analysis

1-163 - Effectiveness of direct oral anticoagulants in prevention of stroke in atrial fibrillation or recurrence of pulmonary embolism or deep vein thrombosis in obese patients

1-048 - Electrocardiogram (ECG) monitoring rates in patients taking QTc-prolonging medications at high risk for Torsades de Pointes (TdP)

1-400 - Establishing a clinical pharmacy technician within the Madison VA anticoagulation clinic

1-227 - Evaluating Direct Oral Anticoagulant Use in Patients with Bioprosthetic Heart Valves

1-004 - Evaluating potential predictors of bleeding events in patients taking direct oral anticoagulants

1-181 - Evaluating the prevalence of veterans on guideline-recommended pharmacologic therapies for heart failure with reduced ejection fraction (HFrEF) at VA Maine Healthcare System

1-239 - Evaluation and characterization of warfarin use in veterans with atrial fibrillation or venous thromboembolism

1-351 - Evaluation of a direct oral anticoagulation (DOAC) stewardship program: analysis of a drug consult review process and population based management tool

1-398 - Evaluation of a warfarin to direct oral anticoagulant switch initiative in patients with poor time in therapeutic range

1-220 - Evaluation of anticoagulation therapy selection in veterans greater than 120 kilograms in a Veterans Affairs (VA) pharmacy clinic

1-088 - Evaluation of appropriateness of bridging using parenteral anticoagulants in patients with atrial fibrillation on warfarin undergoing an elective invasive procedure at a Veterans Affairs Hospital

1-240 - Evaluation of evidence-based medication utilization for the management of heart failure with reduced ejection fraction in a veteran population

1-079 - Evaluation of pharmacy care coordination for patients referred to San Francisco VA Health Care System for cardiology procedures

1-081 - Evaluation of the conversion from warfarin to direct oral anticoagulant in a veteran population

1-340 - Evaluation of the reduction in all-cause mortality and heart failure related hospitalizations with sacubitril/valsartan in a veteran population

1-067 - Hemodynamic variables as predictive markers for cognition

1-117 - Identify factors associated with bleeding events in Veterans prescribed anticoagulants in the outpatient setting

1-134 - Impact of a direct oral anticoagulant (DOAC) population management tool and pharmacist intervention

1-216 - Impact of a pharmacist-led antiarrhythmic drug monitoring outpatient clinic within a Veterans Affairs Medical Center (VAMC)

1-208 - Impact of prophylactic oseltamivir on international normalized ratio (INR) in patients on stable warfarin therapy

1-104 - Impact of transitioning from a traditional anticoagulant clinic to a centralized anticoagulant clinic: A quality improvement project

1-375 - Implementation of a heart failure education class for patients with recent admissions for acute decompensated heart failure

1-252 - Implementing an evidence-based standardized process for evaluation of the planned duration of oral anticoagulant (OAC) therapy in a veteran population

1-300 - Improving time to post-discharge laboratory monitoring after inpatient initiation of aldosterone antagonists for heart failure

1-106 - Investigation of the efficacy and safety of apixaban use in end-stage renal disease

1-005 - Medication use evaluation of digoxin utilization at a rural Veterans Affairs healthcare system

1-047 - Off-label dosing of direct oral anticoagulants for stroke prophylaxis in Veterans with non-valvular atrial fibrillation

1-410 - Pharmacist intervention and the impact on heart failure readmission rates

1-326 - Pharmacist intervention on prescribing patterns of digoxin used as monotherapy for atrial fibrillation in absence of heart failure

1-348 - Rates of venous thromboembolism in hospitalized patients receiving unfractionated heparin thrice daily in higher versus lower BMI patients

1-175 - Retrospective analysis of anticoagulation for atrial fibrillation in a veteran population: a further look at the relationship between obesity and outcomes

1-387 - Retrospective review of the safety and efficacy of direct oral anticoagulants as compared to warfarin in a morbidly obese veteran population

1-365 - Retrospective review on the safety and efficacy of direct oral anticoagulants compared to warfarin in patients with cirrhosis

1-057 - Sacubitril/Valsartan Efficacy in Veterans at Less than Target Doses (SAVE VETS)

1-123 - Safety and efficacy of apixaban versus warfarin in Veterans with end-stage renal disease on dialysis

1-396 - Safety and efficacy of apixaban vs rivaroxaban in morbidly obese VA patients

1-404 - Safety and efficacy of direct oral anticoagulants (DOAC) in obese patients in a Level II VA Medical Center

1-343 - Transitioning the VA Black Hills Health Care System (VA BHHCS) anticoagulation clinic to the direct oral anticoagulant population management dashboard to efficiently monitor patients

1-168 - Utility of the dual antiplatelet therapy score in determining duration of therapy in a veteran population

1-269 - Utilization Review of Existing Heparin Drip Monitoring Protocol

1-085 - Warfarin monitoring in patients with antiphospholipid syndrome at VA Eastern Colorado Health Care System

1-209 - Effect of prior authorization drug requests on patient adherence within a Veterans Affairs health care system

1-007 - Expansion of clinical pharmacy services for the management of hypertensive patients at a Veterans Affairs healthcare system: a quality improvement project

1-037 - Impact of pharmacist interventions on chronic obstructive pulmonary disease (COPD) readmissions in a veteran population

1-341 - Implementation of a pharmacist-managed clinic for patients with concomitant heart failure with reduced ejection fraction (HFrEF), to reduce 30-day readmissions in a rural healthcare setting

1-006 - Implementing a Veterans Affairs collaboration with a school of pharmacy for population management

1-008 - Medication use evaluation of bisphosphonate therapy within a Veteran Affairs healthcare system

1-010 - Assessment of the risk factors for cardiovascular events by framingham risk score and metabolic syndrome risk tool

1-154 - Decentralization of clinical pharmacists and the effects of dashboard-driven patient monitoring in an ambulatory care setting

1-071 - Effect of hospital consumer assessment of healthcare providers and systems (HCAHPS) score through increased patient discharge medication counseling

1-302 - Establishment of a pharmacist-led naloxone distribution service for patients at high risk for opioid overdose

1-289 - Establishment of best documentation practice in an acute care setting at the Cincinnati VA medical center

1-009 - Estimation of cardiovascular disease (CVD) events by use of QRISK a atherosclerosis cardiovascular disease (ASCVD) risk assessments tools in Indian patient

1-409 - Impact of chronic obstructive pulmonary disease (COPD) emergency kit on the prevention of emergency department (ED) visits and/or hospital admissions

1-179 - Impact of pharmacist discharge counseling service on hospital readmission rates and emergency department (ED) visits at a Veterans Affairs Medical Center

1-330 - Impact of pharmacist-led transitions of care services for heart failure patients at Veteran’s Affairs Caribbean Healthcare System at San Juan, PR

1-180 - Implementation of a Cardiovascular Transitions of Care Clinic at a Veterans Affairs Hospital

1-320 - Implementation of a formalized interdisciplinary approach to inpatient diabetes education

1-235 - Implementation of a mail-order medication synchronization program in an Indian Health Services outpatient pharmacy

1-234 - Implementation of a pharmacy-based transitional care program in the emergency department for asthma exacerbation management and prevention

1-319 - Improving Access to Pharmacist-Led Diabetes Care at the Lebanon Veterans Affairs Medical Center (LVAMC)

1-231 - Improving quality of care and financial justification of clinical pharmacy expansion at an Indian Health Service ambulatory care clinic

1-013 - Increasing access to care for rural veterans by leveraging clinical pharmacist providers

1-011 - Optimizing transitions in care through implementing bedside medication delivery and counseling prior to hospital discharge

1-366 - Reduction of Pneumonia-Associated Hospital Readmission Rate With Pharmacist-Led Telehealth Antimicrobial Stewardship Outreach at Veterans Affairs Academic Teaching Facility

1-012 - Targeting best chronic obstructive lung disease (COPD) documentation practices: a pharmacy-collaborative quality improvement project at a veterans healthcare system

1-372 - Evaluation of comprehensive smoking cessation therapy from the clinical pharmacist specialist smoking cessation clinic at the South Texas Veterans Health Care System

1-014 - Evaluation of interdialytic catheter lock protocol conversion in a dialysis unit

1-124 - Evaluation of the implementation of the 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis

1-015 - Switching to infliximab-dyyb results in no differences in clinical outcomes among patients with inflammatory bowel disease (IBD)

1-150 - Evaluation of phenobarbital use for alcohol withdrawal in a veterans affairs medical center

1-393 - Incidence of atrial fibrillation in cardiac surgery patients with and without amiodarone prophylaxis at VA Puget Sound Health Care System (VAPSHCS)

1-017 - Analysis of prescriptions that are not recommended for use together

1-353 - Analysis of testosterone use in male veterans in the setting of opioid cessation or down titration

1-223 - Assessing pharmacist audit and feedback impact on appropriate fluoroquinolone use in Veterans Affairs Health Care System outpatient clinics

1-158 - Assessment of biologic utilization in veterans with psoriasis or psoriatic arthritis

1-113 - Assessment of direct-acting oral anticoagulant prescribing within a Veterans Health Administration emergency department

1-016 - Clinical considerations of sodium-glucose co-transporter 2 inhibitor use in a community setting

1-196 - Cross-sex hormone prescribing and monitoring practices for transgender Veterans within a Veterans Affairs Health Care System

1-101 - Determining appropriate utilization of pharmacotherapy for the treatment of alcohol use disorder at Bay Pines Veterans Affairs Healthcare System

1-018 - Effect of face-to-face and website-based counseling methods in acne vulgaris knowledge improvement and retention among university students in Bekaa governorate, Lebanon, 2018

1-261 - Efficacy and tolerability of empagliflozin or glucagon-like peptide-1 (GLP-1) receptor agonists when added to basal/bolus insulin or oral therapy

1-262 - Efficacy, compliance, and tolerability of alternative dosing of statins in patients with hyperlipidemia

1-275 - Evaluating appropriate outpatient prescribing of lidocaine topical patches within the Veterans Affairs Hudson Valley Health Care System

1-103 - Evaluating the incidence of gabapentin dosing above renal dose recommendations in a Veterans Affairs Healthcare System

1-273 - Evaluation of biologic treatment prescribing and monitoring at a Veterans Affairs (VA) facility

1-045 - Evaluation of febuxostat prescribing practices in patients with cardiovascular disease at a Veterans Affairs medical center

1-197 - Evaluation of inpatient Chronic Obstructive Pulmonary Disease exacerbation management, discharge medication complexity, and outpatient follow-up post-hospitalization at the Minneapolis VA Health Care System

1-192 - Evaluation of liraglutide utilization and veteran candidacy for empagliflozin use in type 2 diabetes

1-096 - Evaluation of partial treatment with hepatitis C regimens in a veteran population

1-193 - Evaluation of patient characteristics for Veteran patients with type 2 diabetes mellitus treated with insulin glargine compared to NPH insulin

1-042 - Evaluation of the utilization of direct oral anticoagulants at a Veterans Affairs medical center

1-384 - Evaluation of varenicline prescribing patterns before and after a formulary status change within a Veterans Affairs facility

1-149 - Medication use evaluation (MUE) of topical combination antibiotic-corticosteroid ophthalmic products in managing acute conjunctivitis in outpatient Veterans

1-327 - Medication use evaluation of anti-MRSA therapy with vancomycin in hospitalized patients with suspected community-onset infections

1-217 - Medication use evaluation of blood glucose test strips in a Veterans Affairs Health Care System

1-102 - Medication use evaluation of statins in patients at high risk for coronary events in a Veterans affairs community based outpatient clinic (CBOC)

1-161 - Pegfilgrastim use evaluation in a tertiary care hospital in the United Arab Emirates

1-087 - Pregabalin prescribing in pain management at a Veterans Affairs Healthcare System after conversion from thrice-daily to twice-daily dosing

1-160 - Usage of bevacizumab in a tertiary care hospital in the United Arab Emirates

1-050 - Analysis of antibiotic administration in patients with sepsis at an Indian Health Service hospital

1-098 - Evaluating opioid prescribing practices in the emergency department within a Veterans Affairs healthcare system

1-257 - Assessment of a medication deprescribing tool on polypharmacy and cost avoidance

1-108 - Effectiveness of high dose trivalent influenza vaccine versus standard dose quadrivalent influenza vaccine in elderly veterans from 2015-2018

1-259 - Evaluating antipsychotic dose reductions in a community living center

1-195 - Evaluation of the monitoring and prescribing habits of primary care providers treating patients with dementia taking acetylcholinesterase inhibitors (AChEI)

1-190 - Examining the use of fall-risk, anticoagulant and antiplatelet medications surrounding patient falls in an inpatient rehabilitation setting

1-297 - Expansion of a geriatric pharmacy post-discharge clinic

1-211 - FAME program: falls assessment of medications in the elderly

1-288 - Impact of pharmacy-directed medication management for patients experiencing falls in a Veterans Affairs Community Living Center

1-247 - Implementation of a self-administration medication program in a Veteran Affairs community living center (CLC)

1-080 - Implementation of a standardized polypharmacy deprescribing process at the San Francisco Veterans Affair healthcare system (SFVAHCS) community living center (CLC)

1-125 - Improving Prescribing Quality for Older Veterans using GRECC Connect and Telehealth

1-381 - Measuring the impact of a clinical pharmacy population health program on deprescribing benzodiazepines and sedative hypnotics in rural and elderly veterans

1-349 - PRescribing Alpha blockers Including praZosin in the Elderly: the PRAIZE safety study

1-167 - Statins for Primary Prevention in Older Adult Veterans (75 years and older) with Diabetes

1-090 - Use of hold parameters with antihypertensive administration in a community living center (CLC) at a Veterans Affairs Hospital

1-178 - Using pharmacist-driven medication reconciliation to identify early manifestations of cognitive impairment in an interprofessional nephrology clinic

1-388 - Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) self-management kits: a retrospective study in veterans within home-based primary care (HBPC)

1-290 - Cellulitis: Home or Inpatient Intravenous (IV) Therapy in a Veteran Population

1-395 - Transition of care process for Home Based Primary Care patients: an analysis of intervention effect on hospitalization rates

1-137 - A medical utilization evaluation (MUE) of associations between diagnostic criteria and antibiotic treatment of urinary tract infections (UTIs) in the outpatient setting

1-321 - Antimicrobial stewardship for acute upper respiratory infections in the outpatient setting

1-205 - Assessing feasibility and impact of a pharmacist-managed Hepatitis B clinic within VA Montana

1-359 - Assessing the impact of an institutional empiric therapy guideline created at a Veterans Affairs medical center for the treatment of urinary tract infections

1-371 - Clinical impact of implementation of rapid diagnostic testing of blood cultures on patient outcomes

1-336 - Clinical impact of rapid diagnostic testing on the duration of broad-spectrum antibiotic use in bacteremia

1-056 - Clinical implications of Methicillin-resistant Staphylococcus aureus (MRSA) colonization nares testing in guiding de-escalation of empiric vancomycin therapy for patients diagnosed with pneumonia

1-058 - Comparison of acute kidney injury in veterans treated with the combination of piperacillin/tazobactam and vancomycin, with veterans treated with vancomycin and meropenem, and vancomycin monotherapy

1-281 - Determining the utility of MRSA nares screening in antimicrobial stewardship

1-116 - Development of an HIV dashboard to identify Veterans at risk for loss to follow-up and improve the HIV care continuum at a Veterans Affairs facility

1-374 - Differences in recurrence rates between cefpodoxime and ciprofloxacin in treating male veterans with cystitis

1-276 - Does magnetic resonance imaging improve patient outcomes in diabetic foot infections?

1-114 - Effect of a respiratory multiplex panel on antimicrobial use in hospitalized patients at a Veterans Affairs hospital

1-021 - Effect of successful hepatitis C treatment on glycemic control and complications of type 2 diabetes mellitus in United States veterans

1-040 - Effects of academic detailing and institutional-specific treatment guidelines on the treatment of urinary tract infections in a Veteran population

1-380 - Evaluating outpatient antibiotic prescribing practices at the Salt Lake City Veterans Affairs Medical Center

1-263 - Evaluating the appropriateness of Staphylococcus aureus bacteremia management in a veteran population

1-399 - Evaluating the effect of anti-retroviral therapy on CD4/CD8 ratios in veterans infected with human immunodeficiency virus

1-034 - Evaluating the effect of the Alaska Native Medical Center procalcitonin (PCT) utilization pathway on clinical decision making: a retrospective review

1-311 - Evaluating the effects of a pharmacy-driven 72-hour antibiotic time-out for empiric broad spectrum coverage with IV vancomycin and/or IV piperacillin/tazobactam

1-183 - Evaluating the impact of implementing a computerized order set for pneumonia on total antibiotic days of therapy at Togus Veterans Affairs Medical Center

1-270 - Evaluation of adherence to infectious disease treatment pathways in the nursing home and community living center (CLC)

1-264 - Evaluation of antibiotic prescribing following emergency room discharge for skin and soft tissue infection

1-314 - Evaluation of antibiotic utilization for urinary tract infections in veterans with urinary catheters residing at a community living center: a retrospective chart review

1-086 - Evaluation of cefdinir and cefuroxime use in a Veterans Affairs (VA) Healthcare System

1-325 - Evaluation of management of skin and soft tissue infections in the inpatient setting in a large Veteran Affairs academic medical center

1-119 - Evaluation of outcomes of 8-week therapy with ledipasvir/sofosbuvir or glecaprevir/pibrentasvir in veterans with hepatitis C infection

1-406 - Evaluation of outpatient fluoroquinolone prescribing at a VA medical center

1-369 - Evaluation of primary prophylaxis initiation in patients at risk for spontaneous bacterial peritonitis (SBP): a quality improvement project at South Texas Veterans Health Care System

1-364 - Impact of a pharmacist-managed sexually transmitted diseases culture review service at a Veterans Affairs medical center

1-226 - Impact of a provider educational intervention to promote safety monitoring in pre-exposure prophylaxis for HIV

1-337 - Impact of adherence to direct-acting antiviral therapy on achievement of SVR12

1-094 - Implementation of a vancomycin dosing program and education for providers at the Washington DC Veterans Affairs Medical Center

1-329 - Implementation of the acute respiratory tract infection campaign at veterans affairs caribbean healthcare system: an initiative to enhance antibiotic prescribing in the ambulatory care setting

1-248 - Implementing a procalcitonin guided protocol to reduce antibiotic prescriptions for acute respiratory infections in the emergency department

1-064 - Implementing indication-specific antibiotic quick orders for pediatric infections in a tribal facility

1-317 - Improvement of Antibiotic Pharmacotherapy by Assessing Timing of Administration

1-199 - Improving judicious antimicrobial prescribing for acute respiratory infections in the outpatient setting: intervention monitoring with an audit and feedback approach

1-070 - Improving Time to Administration of First Dose of Antibiotics by Increasing Accessibility of IV Antibiotics in the Intensive Care Unit

1-099 - Medication use evaluation of compliance to updated Clostridium difficile management guidelines in patients admitted to Bay Pines VA Healthcare System

1-260 - Optimizing medication therapy in HIV patients on cobicistat or ritonavir-based regimens and concurrent statins or inhaled corticosteroids

1-278 - Optimizing treatment in patients with gram negative bacteremia

1-213 - Outcomes of chronic hepatitis C treatment with direct-acting antivirals in patients with slow response to treatment

1-282 - Outpatient antimicrobial stewardship: optimizing patient care via pharmacist led culture review

1-020 - Pharmacy-implemented hepatitis C virus (HCV) point of care (POC) test protocol to increase antibody testing in veteran birth cohort population

1-279 - Prescribing in the outpatient setting: characterizing treatment appropriateness for individual infections and a comparison of prescribing habits based on provider locality

1-019 - Prognostic factors and the impact of infectious disease consultations on the management of candidemia: a tertiary hospital experience in Japan

1-306 - Rate of fluoroquinolone-associated mental status changes in hospitalized veterans being treated for community-acquired pneumonia (CAP)

1-139 - Rates of Antibiotic and Symptomatic Therapy Prescription in Acute Bronchitis and Unspecified Upper Respiratory Tract Infections

1-253 - Reducing the use of antibiotics for asymptomatic bacteriuria in veterans within an ambulatory care setting

1-354 - Retrospective analysis of a pharmacist-driven Staphylococcus aureus bacteremia (SAB) initiative in a community hospital

1-328 - The impact of clinical pharmacist services within a hepatitis C ambulatory care clinic at a Veterans Affairs Medical Center in Puerto Rico

1-066 - Verification of penicillin allergies and implementation of penicillin skin testing in a rural Native American hospital

1-356 - Evaluation of barcode medication administration and computerized prescriber order entry at a veteran affairs’ emergency department

1-229 - Evaluation of the Veterans Health Administration (VHA) automated texting platform on adherence among patients with HIV

1-377 - Increasing intranasal naloxone access to high-risk opioid patients through informatics monitoring and pharmacy workflow incorporation

1-053 - Optimization of prior authorization drug request (PADR) process in a Veterans Affairs health-system

1-111 - Spinal cord satellite pharmacy operation analysis and centralized standardization

1-244 - Determining best practices and improving patient safety of a high-risk medication, alteplase, administered via infusion pumps

1-022 - Quarterly training days: management strategy to engage staff in burnout and depersonalization reduction

1-068 - Impact of a plant-based blood pressure education program and empowerment tools in managing hypertensive patients: the BEET program

1-060 - A multi-center retrospective study evaluating palliative antineoplastic therapy administered and medication de-escalation in Veteran cancer patients toward the end-of-life

1-255 - Comparison of real-world outcomes associated with use of atezolizumab, nivolumab, and pembrolizumab for metastatic non-small cell lung cancer (NSCLC) in veterans

1-335 - Describing the practice and role of a pharmacist in an oral chemotherapy clinic

1-140 - Effect of concomitant gastric acid suppression (GAS) therapy with oral tyrosine kinase inhibitors in different malignancies

1-159 - Effectiveness of regorafenib after trifluridine/tipiracil-line for refractory metastatic colorectal cancer

1-055 - Efficacy and safety of zoledronic acid in veterans with bone metastases

1-169 - Evaluating palliative antineoplastic therapy administered and medication de-escalation in veteran cancer patients toward the end-of-life

1-077 - Evaluating the incidence and severity of immune-related adverse events in veteran cancer patients treated with immunotherapy

1-373 - Evaluation of Nivolumab Use in Advanced Hepatocellular Carcinoma at the South Texas Veterans Health Care System (STVHCS)

1-118 - Evaluation of the potential discontinuation or de-escalation of tyrosine kinase inhibitors in patients with Philadelphia chromosome chronic myeloid leukemia among the veteran population

1-074 - Evaluation of the potential use of rituximab 60-minute short infusion and subcutaneous injection in a Veterans Affair hospital

1-254 - Improving workflow of an oncology pharmacy clinic to improve efficiency and clinical outcomes

1-189 - Infection Rates of Daratumumab and Elotuzumab Containing Regimens in Patients with Relapsed or Refractory Multiple Myeloma

1-093 - Prevalence and management of adverse effects of programmed death-1 and programmed death ligand-1inhibitors in veterans with cancer treated at the Washington DC VA Medical Center

1-023 - Therapeutic adherence study to oral oncological medications

1-210 - Use and toxicity of zoledronic acid for bone involvement in veterans with breast cancer, prostate cancer, and multiple myeloma

1-350 - Use of biosimilar granulocyte colony-stimulating factor (G-CSF) for mobilization in autologous and allogeneic hematopoietic stem cell transplantation (HSCT) in a veteran population

1-386 - Buprenorphine use in patients with therapeutically acquired complex persistent opioid dependence (CPOD): patient characteristics, treatment retention, and cost-savings

1-024 - Customized health information technology effectively directs care delivery in veterans undergoing orthopedic surgery

1-218 - Establishing an integrated chronic pain management clinic in a rural healthcare facility serving American Indians and Alaska Natives

1-121 - Evaluating utilization and outcomes of the prescription drug monitoring program (PDMP) within the West Palm Beach Veterans Affairs Healthcare System

1-112 - Evaluation of concomitant opioid-benzodiazepine use and patient safety within a Veteran Affairs Healthcare System

1-251 - Evaluation of efficacy and safety of sublingual buprenorphine containing products in managing chronic pain in a veteran population

1-144 - Evaluation of prescribing patterns at the Jesse Brown Veterans Affairs Medical Center of hydrocodone/acetaminophen after rescheduling by the Drug Enforcement Administration (DEA)

1-132 - Evaluation of the effect of opioid prescribing at discharge post total knee or hip arthroplasty on future opioid use within a Veteran’s Affairs Medical Center

1-038 - Impact of a whole health approach utilizing shared medical appointments on opioid safety in a veteran population

1-078 - Implementation of a data-based and opioid risk mitigation pilot program in veterans receiving total hip and knee arthroplasty at San Francisco VA Health Care System

1-128 - Implementation of a pharmacy-driven transitions-of-care post discharge pain management program

1-390 - Improving naloxone education and distribution in patients at the VA Puget Sound

1-233 - Ketamine infusion as an alternative treatment for pain and depression: implementing administration policies and procedures at a rural Indian Health Service facility

1-221 - Opioid tapering in Veterans Affairs pharmacist-run medication therapy management clinics

1-272 - Perioperative pain management protocol for patients on chronic buprenorphine therapy undergoing elective or emergent surgery

1-172 - Peripheral nerve block via disposable ropivacaine infusion pumps and its effects on opioid use in veterans undergoing primary total knee replacement

1-361 - Prevalence of long term opioid dependence in opioid naïve patients receiving opioid infusions for analgesia in the intensive care unit setting

1-347 - Reduction of opioid-benzodiazepine combination outcomes

1-120 - Retrospective review of multimodal analgesia for postoperative orthopedic patients in a VA setting

1-182 - Self-reported pain outcomes in Veterans receiving high dose chronic opioid therapy following implementation of state mandated opioid tapers within the VA Maine Healthcare System

1-355 - Success rate of pharmacist assisted opioid taper at the Central Texas Veterans Health Care System for local quality improvement

1-271 - Variability in Opioid Dose Taper Among Clinicians

1-405 - A Retrospective Analysis of Initial Vancomycin Dosing Protocols at the Hershel “Woody” Williams Veteran’s Affairs Medical Center in Huntington, WV

1-202 - Evaluation of patient-specific versus population-based parameters in estimation of vancomycin area under the concentration versus time curve/minimum inhibitory concentration (AUC/MIC)

1-025 - Therapeutic drug monitoring of ustekinumab in psoriasis patients with good response

1-249 - Developing a quality assurance (QA) program for compounded sterile preparations (CSP) utilizing comprehensive gap analysis

1-362 - Enhancing employee education and retention of regulatory compliances in a Veterans Affairs academic teaching hospital to improve non-sterile compounding practices and strengthen quality assurance

1-191 - Assessing knowledge of depression and comfort with mental health in pharmacy residents: a survey of Veterans Affairs pharmacy preceptors

1-333 - Closing the gap: Raising medical professionals' transgender awareness and medical proficiency through pharmacist-led education

1-026 - Introductory overview session and its effect on student performance

1-242 - Outcomes of implementing a clinical development program for pharmacists working in an Indian Health Service facility

1-331 - Adherence and cost outcomes associated with multi-blister medication packaging for Veterans with mental health intensive case management (MHICM) at Providence Veterans Affairs Medical Center (PVAMC)

1-059 - Adjunctive gabapentin therapy for alcohol withdrawal syndrome

1-194 - Algorithm to Identify Next-Step Pharmacological Antidepressant Strategies among Veterans

1-286 - Analysis of the use of abortive therapy agents in treatment of migraines at the Chillicothe Veterans Affairs Medical Center

1-206 - Analyzing the effectiveness of a pharmacist managed outpatient benzodiazepine taper clinic at a Veterans Affairs medical center

1-131 - Antipsychotic Polypharmacy and Appropriateness for Clozapine Therapy

1-360 - Assessing refill data among different classes of antidepressants in a veteran population to improve adherence

1-382 - Central nervous system polypharmacy and factors identified to reduce suicide-related behaviors

1-203 - Decreasing the co-prescribing of stimulants and benzodiazepines: a quality improvement study

1-027 - Doxazosin for the treatment of nightmares and night sweats in a veteran population

1-083 - Drug interactions and pharmacokinetic changes with a carbamazepine taper

1-294 - Drug-Drug Interactions with Antipsychotic and Antiarrhythmic Medications

1-186 - Effect of benzodiazepine receptor agonists in Veterans with post-traumatic stress disorder (PTSD)

1-250 - Establishing a pharmacist-managed outreach clinic at a day shelter for homeless Veterans

1-412 - Evaluating completion rates of a metabolic monitoring tool versus actual laboratory monitoring in patients receiving second-generation antipsychotics

1-143 - Evaluating the impact of medication-assisted treatment for alcohol use disorder on hospitalization rates in a veteran population

1-092 - Evaluation of efficacy of intramuscular naltrexone use for opioid use disorder

1-310 - Evaluation of marijuana use in Veterans admitted to a VA psychiatric ward

1-237 - Evaluation of metabolic monitoring in patients on antipsychotic therapy at a Veterans Affairs Health Care System

1-385 - Evaluation of metabolic monitoring practices for patients taking second generation antipsychotics

1-091 - Evaluation of metabolic side effects associated with patients maintained on lurasidone

1-299 - Evaluation of national Veterans Affairs clozapine prescribing rates

1-309 - Evaluation of pharmacotherapy for treatment of alcohol use disorder in veterans

1-367 - Evaluation of pimavanserin related mortality in a veterans affairs medical center

1-089 - Evaluation of safety and efficacy of quarterly paliperidone palmitate injection for the management of psychiatric disorders in a Veterans Affairs Healthcare System

1-122 - Evaluation of the utility and impact of the electronic consult (econsult) tool for mental health and behavioral science

1-076 - False-positive amphetamine urine drug screen secondary to commonly used medications: A case series

1-383 - Identifying psychological factors for intervention and treatment adherence

1-280 - Implementation and evaluation of a psychotropic drug safety monitoring service

1-127 - Implementation of a pharmacist-led medication-assisted treatment (MAT) clinic at a Veterans Affairs medical center

1-028 - Implementation of clinical pharmacy services in the management of alcohol use disorder at a rural Veterans Affairs healthcare system: a quality improvement project

1-142 - Interdisciplinary implementation of mental health screenings and treatment in a human immunodeficiency virus (HIV) clinic at a federal health care center

1-054 - Investigating the prescribing and monitoring practices for antidepressants in the primary care setting in regards to appropriateness for the diagnosis of depression and anxiety

1-236 - Ketamine for the treatment of mood disorders in a veteran population: a medication use evaluation

1-075 - Long acting injectable antipsychotics: evaluating injection timing and its effect on patient outcomes at VA Central California Healthcare System (VACCHCS)

1-170 - Methods Implemented by Outpatient Providers to Discontinue Benzodiazepine Therapy in Patients on Concurrent Opioids

1-082 - Observation of antipsychotic polypharmacy at the Veterans Affairs Central California Health Care System (VACCHCS)

1-165 - Perceived Barriers to Clozapine Prescribing: A National Survey of VA Mental Health Providers

1-313 - Pharmacist impact on compliance rate of metabolic monitoring among Veterans receiving antipsychotic medications

1-177 - Predicting adverse metabolic effects when initiating olanzapine: an assessment of patient characteristics

1-283 - QA/QI project to assess the efficacy of a recently established pharmacist-managed taper service in reducing inappropriate benzodiazepine prescriptions in the elderly through direct patient education

1-277 - Quality Assurance Initiative to Assess Risk factors and Management Strategies Prior To Suicide Attempts/Completions and Following Suicide Attempts in the Veteran Population

1-151 - Relapse rates among Veterans on maintenance doses of combination buprenorphine and naloxone for opioid use disorder

1-379 - Retrospective evaluation of inpatient alcohol withdrawal admissions to determine appropriateness for ambulatory detoxification

1-062 - Risk factors for new and persistent chronic opioid use in U.S. veterans undergoing major orthopedic surgery: a retrospective case-control study

1-339 - Safety of low dose quetiapine in a veteran population

1-224 - Tools for population management of lithium laboratory monitoring: a medication use evaluation

1-155 - Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans

1-394 - Analyzing the appropriateness of antibiotic prescribing in a Veterans Affairs Home Based Primary Care setting

1-267 - Assessing the effectiveness of academic detailing in increasing naloxone prescriptions in patients with Opioid Use Disorder at Northport Veterans Affairs Medical Center

1-232 - Assessment of consolidated mail outpatient pharmacy (CMOP) utilization in Indian health service (IHS)

1-246 - Assessment of opioid chronicity, discontinuation and continuation in suicidality: a VA quality improvement project

1-184 - Bleeding comparison of apixaban versus warfarin in veteran patients at VA Maine Healthcare System

1-200 - Comparison of the Johns Hopkins Fall Risk Assessment Tool to her Morse Fall Risk Scale as an Accurate Predictor of Fall Risk in CLC/PCU Veterans

1-115 - Development and evaluation of a pharmacy-focused hazardous drugs competency program at a Veterans Affairs medical center

1-318 - Development and implementation of naloxone distribution protocol at the Lebanon Veterans Affairs Medical Center

1-029 - Effective methods to detect medication errors in surgical wards by clinical pharmacist at a tertiary care hospital in Bangalore: a single blinded prospective observational study

1-352 - Effectiveness of post-discharge education on reducing proton pump inhibitor usage in conjunction with stewardship efforts

1-307 - Effects of a pharmacy-led educational intervention on penicillin allergy documentation in an ambulatory care setting

1-403 - Evaluating the impact of a pharmacist-led renal dosing protocol on dose adjustments in a Veterans Affairs medical center

1-301 - Evaluation and improvement of the timeliness of antibiotic administration at a tertiary care veterans affairs medical center

1-295 - Evaluation of a pharmacist driven medication reconciliation and delivery service

1-315 - Evaluation of a pharmacist-led outpatient medication reconciliation program for American Indian and Alaska Native patients

1-039 - Evaluation of a pharmacy-managed amiodarone monitoring clinic in a veteran population

1-031 - Evaluation of adverse drug reactions related clinical decision support alert overrides in the inpatient setting

1-378 - Impact of a clinical decision-support tool on venous thromboembolism prophylaxis in acutely ill medical patients

1-408 - Impact of prior authorization drug reviews on safety outcomes in newly initiated direct-acting oral anticoagulants

1-130 - Implementation and impact of a pharmacist-run gout clinic in the veteran population

1-258 - Implementation of a clinical reminder to increase adherence to amiodarone monitoring

1-126 - Implementation of a vaccine order set with evidence-based recommendations into a computerized electronic health record system

1-215 - Implementation of pharmacist-led direct oral anticoagulant candidate screening process within current anticoagulation clinic panel in a veteran population

1-204 - Implementation of the overdose education and naloxone distribution (OEND) for at risk patients of national priority providers: A quality improvement project

1-157 - Implementation of USP Chapter standards in a Veterans Affairs Medical Center

1-322 - Initiation and Use of Naltrexone Extended-Release (ER) Injection in the Veteran Population

1-032 - Interdisciplinary medication event team’s process improvement for handling of inpatient concentrated regular insulin U-500

1-316 - Methadone quality improvement analysis at the Corporal Michael J. Crescenz VA medical center

1-397 - Pharmacy-driven antibiotic stewardship quality improvement project

1-164 - Prescribing Practices of Stimulants within a VA Health Care System

1-030 - Prospective study on off-label use of anesthetics and analgesic in a tertiary care hospital-clinical pharmacist intervention

1-392 - Proton pump inhibitor deprescribing in the primary care and discharge patient population

1-346 - Retrospective analysis of local antiemetic use in highly emetogenic chemotherapy versus current guideline recommendations

1-176 - Retrospective analysis of medication-related heart failure readmissions in a veteran population

1-407 - Retrospective review of statin-induced myopathy-myalgia at a veterans affairs medical center

1-256 - Risk factors associated with progression to metabolic syndrome after initiation of an atypical antipsychotic in a veteran population

1-268 - Utilization of a proton pump inhibitor (PPI) de-escalation protocol among geriatric patients at Northport Veterans Affairs Medical Center (VAMC)

1-049 - Implementation and effectiveness of continual glucose monitoring to improve glycemic control within a pharmacy run diabetes clinic in a rural Native American medical center

1-035 - Increasing vaccination rates by breaking down education and hesitancy barriers through targeted education for community health aides (CHAs) in rural Alaska

1-401 - Pharmacist impact on vaccination rates in cardiothoracic transplant recipients

1-245 - Risk of infratherapeutic levels of Tacrolimus after Hepatitis C virus infection clearance in kidney transplant recipients

1-033 - Assessing the suitability and efficacy of a single dose intramuscular methotrexate in ectopic pregnancy at a tertiary care obstetric setting in Qatar

1-153 - Assessment of menopausal symptom management by a clinical pharmacist vs. primary care provider in a Veterans Affairs medical center

1-138 - Assessment of reproductive outcomes in women Veterans identified as not preventing pregnancy while on teratogenic medications

1-156 - Comparison of medication assisted treatment for opioid use disorder in male and female veterans

1-363 - Documentation of contraceptive counseling of potentially teratogenic medications prescribed in female Veterans of reproductive age